The price of Ethereum has surged more than 20% since the beginning of this week, breaching the $3800 level, following reports of possible approval of Ethereum spot funds (ETFs) by the US Securities and Exchange Commission (SEC) this week. The earliest possible approval could take place on July 23, while the Polymarket contract suggests a 55% probability of approval by May 31.
SEC's attitude change:
The SEC was initially expected to reject applications for Ethereum ETFs due to a lack of cooperation from the authority. However, reports surfaced yesterday that the SEC has accelerated the 19b-4 application process, suggesting progress toward approval. Bloomberg analysts raised their expectations for approval of Ethereum ETFs to 75%. The SEC's change of heart is likely due to growing political pressure ahead of the upcoming US elections.
What is the price situation?
Ethereum scores on Monday its best session since 2022. In addition, this week's growth already exceeds 20%. Nevertheless, the price is still about 7% from the March peaks and 27% from the historical maxima of 2021. It is also worth noting that there has been increased interest in call options on Ethereum with a strike price of $4,000. Of course, it is worth remembering that there could be disappointment and rejection of applications for Ethereum ETFs, which could lead to a complete price retreat. Nevertheless, as Bitcoin's situation shows, the inflow of funds in the last four business days has led to a rise above $70,000.

Source: xStation5

There has been a breakout of the 1-year and 5-year averages. The last time a similar signal occurred was in 2021, which led to a continuation of the powerful multi-month rise. Source: Bloomberg Finance LP, XTB
Morning Wrap: Ceasefire Fuels Wall Street Gains, but Political Uncertainty Remains
Bitcoin surges almost 4% to the highest level since the beginning of February 2026
Daily Summary: As a ceasefire drifts away, markets lose ground
Chart of the day 📈Bitcoin rebounds above $76k trying to reverse the trend (21.04.2026)
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.